How do you pay?

How to pay the least

Ask for the cash price

Hympavzi

Hympavzi is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Hympavzi’s cash price, and one or two other pharmacies too.
  2. Hympavzi’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameHympavzi
Authorized genericmarstacimab-hncq
Regular genericmarstacimab-hncq
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Hympavzi?
The original
–
–

Brand nameThe maker’s card

HYMPAVZI Co-pay Savings Program

Savings card from Pfizer

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a fill

The card takes up to $15,000 a year off your co-pay.

Sign up on hympavzi.com 

Or call 1-888-733-2030. See the offer on hympavzi.com

In the maker’s words

“Eligible patients with commercial prescription drug insurance coverage for HYMPAVZI® may pay as little as $0 per prescription fill.”

From the maker’s offer on hympavzi.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Hympavzi itself, from the same company, sold without the brand name, and usually for less. For now Hympavzi is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Hympavzi is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

HYMPAVZI is a tissue factor pathway inhibitor (TFPI) antagonist indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 6 years of age and older with:

  • hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors, or
  • hemophilia B (congenital factor IX deficiency) with or without factor IX inhibitors.

Source: the FDA label for Hympavzi (Pfizer Laboratories Div Pfizer Inc), June 22, 2026. Full label on DailyMed 

Good to know